Relevance of Interleukins 6 and 8 Single Nucleotide Polymorphisms in Prostate Cancer: A Multicenter Study

Table 1

Comparison of PSA levels of the affected and the control groups.

Prostate-specific antigen (PSA)	PCa patients (n = 40)	BPH patients (n = 40)	Control (n = 40)
S. urea (mg/dl)	26.6 ± 5.7	14.3 ± 2.8	12.7 ± 3.1	<0.001
S. creatinine (mg/dl)	1.2 ± 0.2	0.9 ± 0.1	0.8 ± 0.3	<0.001
Total PSA (ng/ml)	4.8 ± 0.9	2.5 ± 0.9	1.8 ± 0.5	<0.001
PSA ratio %	37 ± 7.5	17.5 ± 3.4	10.5 ± 3.1	<0.001

Data are represented by mean ± SD, : value for comparing between the studied groups. Statistically significant at  ≤ 0.05.